Viking Therapeutics: Cash Burn & Valuation
Viking Therapeutics (VKTX) is rated STRONG SELL because heavy cash burn is consuming a large cash balance while the stock still trades at a rich valuation. Phase 3 obesity progress…
Read the researchIndependent equity research
Stock research.
The evidence behind the view.
Company analysis, SEC filing changes and public follow-ups. Read the thesis, inspect the assumptions, and see what happened next.
Free research to read now. Premium research is coming.
Latest company analysis
New to LF0?
Three ways to start.
Understand a thesis. Audit a call. Compare a filing.
01 / Read a stock thesis
FormFactor (FORM): AI Growth vs. Valuation
FormFactor (FORM) is rated Hold as strong AI-linked demand is offset by a valuation that already prices in much of the recovery. Q1 2026 showed revenue growth, but EBITDA softened…
Read the research02 / Check the follow-up
The Scorecard: 3 Month Update: TTWO Sell — Correct so far
Revisiting our Sell call on TTWO: entry $247.62, latest $201.28, -18.7%.
Read the research03 / See what changed
Zedge (ZDGE) 10-K: Business Changes Lead 28 October 2026 Filing Roundup
Zedge (ZDGE)'s Business section changed the most among 5 companies that filed 10-Ks on 28 October 2026, each compared against its prior-year filing.
Read the researchFrom the research desk
Find your next read.
Company analysis
Viking Therapeutics: Cash Burn & Valuation
Viking Therapeutics (VKTX) is rated STRONG SELL because heavy cash burn is consuming a large cash balance while the stock still trades at a rich valuation. Phase 3 obesity progress…
Read the researchConagra Brands: Valuation, Margin Repair & Leverage
Conagra Brands (CAG) is rated Hold as cash generation and a fair valuation offset weak earnings conversion and elevated leverage. The stock’s 6.3% free cash flow yield supports the case,…
Read the researchPower Solutions International: Valuation & Free Cash Flow
Power Solutions International (PSIX) is rated Hold as cash generation and profitability support the business, but the recovery is still uneven. The stock looks fairly valued after a 20.5% TTM…
Read the researchSEC filing changes
Zedge (ZDGE) 10-K: Business Changes Lead 28 October 2026 Filing Roundup
Zedge (ZDGE)'s Business section changed the most among 5 companies that filed 10-Ks on 28 October 2026, each compared against its prior-year filing.
Read the researchSimply Good Foods (SMPL) 2026 10-K Analysis: Business Changes
Simply Good Foods (SMPL) 2026 10-K analysis comparing the 27 October 2026 filing with its prior-year 10-K, highlighting the Business section's biggest changes.
Read the researchPricesmart (PSMT) 10-K: Business Changes Lead 26 October 2026 Filing Roundup
Pricesmart (PSMT)'s Business section changed the most among 4 companies that filed 10-Ks on 26 October 2026, each compared against its prior-year filing.
Read the researchCall follow-ups
The Scorecard: 3 Month Update: TTWO Sell — Correct so far
Revisiting our Sell call on TTWO: entry $247.62, latest $201.28, -18.7%.
Read the researchThe Scorecard: 2 Month Update: NXE Sell — Correct so far
Revisiting our Sell call on NXE: entry $10.40, latest $8.80, -15.4%.
Read the researchThe Scorecard: 1 Month Update: DOCN Sell — Correct so far
Revisiting our Sell call on DOCN: entry $136.29, latest $106.39, -21.9%.
Read the researchLF0 Research Desk
Know how the research works.
A rating is a thesis to examine. The original analysis and later scorecard reviews let you see both the reasoning and the outcome.
Stay connected
Like the research?
Be first to hear about premium.
The current research is free to browse. The waitlist is for news about deeper premium analysis when it launches.
This form joins the LF0 premium waitlist. Substack is a separate subscription. You can read the current research without joining either.
Follow your interests
Find a company or sector.
Basic MaterialsCommunication ServicesConsumer CyclicalConsumer DefensiveEnergyFinancial ServicesHealthcareIndustrialsReal EstateTechnologyUtilities
More company research
Explore more of the company analyses featured on LF0.
- Adtran Holdings: ADTN Margins, Cash Flow, Valuation & Turnaround Risk
- Amkor Technology: AMKR Free Cash Flow, Valuation & Customer Concentration
- Clover Health: Valuation & Margins, Cash Flow
- Eos Energy Enterprises: EOSE Cash Burn, Revenue Growth & Financing Risk
- Fluence Energy (FLNC): Backlog vs. Cash Burn
- GeneDx: Valuation, Cash Flow & Margins
- Kimbell Royalty Partners: KRP EBITDA, Leverage, Distribution Risk & Valuation
- NuScale Power: SMR Valuation, Cash Burn, Backlog & Commercialization Risk
- Remitly Global: Valuation, Growth, Margins & Cash Flow